23.35Open23.35Pre Close0 Volume15 Open Interest55.00Strike Price0.00Turnover260.34%IV2.54%PremiumDec 20, 2024Expiry Date21.41Intrinsic Value100Multiplier3DDays to Expiry1.94Extrinsic Value100Contract SizeAmericanOptions Type0.9189Delta0.0076Gamma3.43Leverage Ratio-0.3933Theta0.0048Rho3.16Eff Leverage0.0115Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet